IRCT20211203053263N2已完成3 期
Comparison of the effect of bosentan with routine protocol on clinical outcomes of hospitalized patients with COVID-19 infection.
Ilam University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Written informed consent prior to initiation of study.
- •Age over 18 years.
- •Laboratory-confirmed SARS-CoV-2 infection determined by PCR less than 72 hours before randomization.
- •Illness of any duration, and at least one of the following:Radiographic infiltrates by imaging , OR Clinical assessment (evidence of rales/crackles on exam) AND SpO2 = 94% on room air, OR Requiring mechanical ventilation and/or supplemental oxygen.
- •Women of childbearing potential must agree to use at least one primary form of contraception for the duration of the study.
排除标准
- •Pregnancy or Lactation
- •Glibenclamide Consumption
- •Cyclosporine Consumption
- •Aminotransferases > 3 times normal
- •Allergy to bosentan
研究者
相似试验
已完成
3 期
Bosentan for high-risk outpatients with COVID-19IRCT20211203053263N1Ilam University of Medical Sciences350
招募中
2 期
The effect of Bosentan in the treatment of pulmonary hypertension in patients with COVID-19Condition 1: COVID-19. Condition 2: COVID-19.COVID-19, virus not identifiedCOVID-19, virus identifiedU07.2U07.1IRCT20210710051831N1Qazvin University of Medical Sciences60
进行中（未招募）
不适用
Comparaison des effets du bosentan et de la pression positive continue sur les complications cardiovasculaires du syndrome d’apnées du sommeil - BOSASEUCTR2007-005333-11-FRniversity Hospital of Grenoble
已完成
不适用
Comparison of the efficacy between Bofutsushosan and Daisaikoto in sleep apnea patients complicated with persistent obese and hypertensioObstructive sleep apnea syndrome, Hypertension, ObesityJPRN-UMIN000003981Kyoto University,Graduate School of Medicine,Department of respiratory medicine152
进行中（未招募）
不适用
Safety and efficacy study of bosentan in progressive pulmonary sarcoidosis - BOPSACProgressive pulmonary sarcoidosisMedDRA version: 9.1Level: PTClassification code 10037430Term: Pulmonary sarcoidosisEUCTR2007-005117-18-ATMedical University of Vienna, Department of Clinical Pharmacology